Anglo-Swedish pharmaceuticals giant AstraZeneca on Thursday agreed to buy French biotech specialist Amolyt Pharma for about $1 billion, expanding further into the field of rare drugs.
Mar 14, 2024
0
0
Swiss pharmaceutical giant Novartis said this week it had agreed to buy German biotech firm MorphoSys for 2.7 billion euros ($2.9 billion), giving it access to a new blood cancer treatment.
Feb 6, 2024
0
0
Danish pharmaceutical giant Novo Nordisk on Thursday announced a major investment in a French production site to expand capacity including for a blockbuster anti-obesity drug.
Nov 23, 2023
0
1
Swiss pharmaceutical group Roche said Monday it will pay $7.1 billion to buy Telavant Holdings, a group developing new treatments for inflammatory bowel diseases.
Oct 23, 2023
0
0
Shares in Japan's Daiichi Sankyo soared on Friday after the pharma group announced a major cancer drug deal with US giant Merck worth up to $22 billion.
Oct 20, 2023
0
1
The EU said Thursday it had given the green light for US pharmaceutical giant Pfizer's $43-billion acquisition of biotech firm Seagen, specializing in innovative cancer treatment.
Oct 19, 2023
0
0
US pharmaceutical company Bristol Myers Squibb announced a $4.8 billion deal on Sunday to acquire cancer drugmaker Mirati Therapeutics.
Oct 9, 2023
0
1
Swiss pharmaceutical giant Novartis said Monday that it had reached a deal to buy US kidney treatment developer Chinook Therapeutics for up to $3.5 billion.
Jun 12, 2023
0
2
The World Health Organization on Thursday warned against "fake news" after Twitter boss Elon Musk tweeted that countries should not "cede authority to WHO" amid negotiations over a new pandemic treaty.
Mar 23, 2023
0
4
US pharmaceutical giant Pfizer announced Monday that it had reached a deal to buy biotech firm Seagen, specializing in innovative cancer treatment, for $43 billion.
Mar 13, 2023
0
2
